S.E.E.D. Planning Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,344
Closed -$204K 77
2024
Q1
$204K Sell
2,344
-199
-8% -$17K 0.07% 75
2023
Q4
$209K Sell
2,543
-553
-18% -$42.1K 0.08% 78
2023
Q3
$243K Sell
3,096
-4,721
-60% -$395K 0.09% 71
2023
Q2
$689K Sell
7,817
-1,534
-16% -$132K 0.24% 52
2023
Q1
$754K Buy
9,351
+2,333
+33% +$190K 0.29% 48
2022
Q4
$545K Sell
7,018
-1,931
-22% -$157K 0.24% 52
2022
Q3
$723K Buy
8,949
+1,294
+17% +$116K 0.34% 46
2022
Q2
$687K Sell
7,655
-12,034
-61% -$1.22M 0.31% 46
2022
Q1
$2.18M Buy
19,689
+9,715
+97% +$1.03M 0.93% 36
2021
Q4
$1.03M Buy
9,974
+6,582
+194% +$762K 0.45% 44
2021
Q3
$425K Buy
3,392
+352
+12% +$45.6K 0.2% 55
2021
Q2
$377K Buy
3,040
+304
+11% +$38.2K 0.19% 62
2021
Q1
$323K Buy
2,736
+164
+6% +$19.2K 0.18% 62
2020
Q4
$301K Sell
2,572
-229
-8% -$25.2K 0.18% 56
2020
Q3
$291K Buy
+2,801
New +$281K 0.21% 54
2020
Q1
Sell
-3,435
Closed -$390K 57
2019
Q4
$390K Buy
+3,435
New +$377K 0.34% 46

Other funds holding MDT

S.E.E.D. Planning Group's MDT Position: Q2 2024 in Review

S.E.E.D. Planning Group sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,344 shares — an estimated $204K sold.

S.E.E.D. Planning Group first reported a position in MDT in Q4 2019 and held it in 16 quarters. The position peaked at $2.18M in Q1 2022. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • S.E.E.D. Planning Group reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • S.E.E.D. Planning Group sold 2,344 Medtronic shares in Q2 2024, an estimated $204K.
  • S.E.E.D. Planning Group first reported a position in Medtronic in Q4 2019 and held it in 16 quarters.
  • S.E.E.D. Planning Group's Medtronic position peaked at $2.18M in Q1 2022.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on S.E.E.D. Planning Group's 13F filing for Q2 2024, filed 18 Jul 2024.